Ferrlecit



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Iron Deficiency Anaemia 32.0%
Drug Use For Unknown Indication 23.9%
Anaemia 15.1%
Iron Deficiency 8.6%
Blood Pressure 3.0%
Hypertension 2.4%
Pain 1.9%
Renal Failure Chronic 1.6%
Supplementation Therapy 1.6%
Premedication 1.3%
Thrombosis Prophylaxis 1.3%
Crohn's Disease 1.1%
Gastric Disorder 1.1%
Erysipelas 0.8%
Iron Deficiency Anemia 0.8%
Malabsorption 0.8%
Prophylaxis 0.8%
Renal Disorder 0.8%
Anemia 0.5%
Anxiety 0.5%
Vomiting 28.2%
Urticaria 10.0%
Syncope 7.1%
Dyspnoea 4.7%
Nausea 4.7%
Paraesthesia 4.7%
Oedema Peripheral 4.1%
Urinary Incontinence 4.1%
Swollen Tongue 3.5%
Faecal Incontinence 2.9%
Pruritus 2.9%
Rash 2.9%
Throat Tightness 2.9%
Unresponsive To Stimuli 2.9%
Death 2.4%
Hypotension 2.4%
Loss Of Consciousness 2.4%
Oxygen Saturation Decreased 2.4%
Tachycardia 2.4%
Wrong Technique In Drug Usage Process 2.4%
Secondary
Drug Use For Unknown Indication 26.8%
Iron Deficiency Anaemia 17.8%
Premedication 10.3%
Blood Pressure 5.6%
Supplementation Therapy 4.7%
Antidepressant Therapy 3.8%
Hypertension 3.8%
Iron Deficiency 3.8%
Pain 3.8%
Anaemia 2.8%
Foetal Exposure During Pregnancy 2.8%
Malabsorption 2.3%
Gastrooesophageal Reflux Disease 1.9%
Prophylaxis 1.9%
Thrombosis Prophylaxis 1.9%
Depression 1.4%
Product Used For Unknown Indication 1.4%
Renal Failure Chronic 1.4%
Anxiety 0.9%
Back Pain 0.9%
Vomiting 22.4%
Weight Decreased 16.3%
Faecal Incontinence 8.2%
Urinary Incontinence 8.2%
Oxygen Saturation Decreased 6.1%
Stomatitis 6.1%
Blood Urea Increased 4.1%
Pruritus 4.1%
Cardiac Failure Congestive 2.0%
Cyanosis 2.0%
Death 2.0%
Dizziness 2.0%
Dyspnoea 2.0%
Extravasation 2.0%
Hypotonia 2.0%
Joint Swelling 2.0%
Klebsiella Bacteraemia 2.0%
Loss Of Consciousness 2.0%
Off Label Use 2.0%
Presyncope 2.0%
Concomitant
Product Used For Unknown Indication 59.4%
Drug Use For Unknown Indication 10.4%
Nuclear Magnetic Resonance Imaging 6.6%
Hyperparathyroidism Secondary 4.2%
Hypertension 4.1%
Angiogram 2.7%
Anaemia 2.1%
Renal Failure Chronic 2.0%
Pain 1.5%
Iron Deficiency Anaemia 1.0%
Hyperparathyroidism 1.0%
Nausea 1.0%
Nuclear Magnetic Resonance Imaging Brain 0.6%
Pneumonia 0.6%
Renal Failure 0.6%
Hyperphosphataemia 0.5%
Supplementation Therapy 0.5%
Dialysis 0.5%
Computerised Tomogram 0.4%
Diarrhoea 0.4%
Drug Ineffective 11.5%
Skin Tightness 11.0%
Therapeutic Response Decreased 7.0%
Death 6.0%
Shunt Occlusion 6.0%
Shunt Thrombosis 4.5%
Syncope 4.5%
Cardiac Arrest 4.0%
Cardiac Failure 4.0%
Nephrogenic Anaemia 4.0%
Pneumonia 4.0%
Renal Failure Acute 4.0%
Subcutaneous Nodule 4.0%
Thrombocytopenia 4.0%
Vertigo 4.0%
Weight Decreased 4.0%
Anaemia 3.5%
General Physical Health Deterioration 3.5%
Hospitalisation 3.5%
Pericardial Effusion 3.0%